- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07951177
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion. (PED-MR)
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion: a Multicenter Randomized Study Versus Standard Treatment.
The goal of this clinical investigation is to evaluate the effectiveness of ETD + standard treatment versus standard treatment only, on the improvement of the tympanic membrane retraction, up to 18 months after intervention in children aged ]8-17[ with posterior mesotympanic retraction and middle ear effusion.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Fabian BLANC, Dr
- Telefonnummer: +33 0668248182
- E-post: fabian-blanc@chu-montpellier.fr
Studieorter
-
-
-
Montpellier, Frankrike, 34000
- Fabian BLANC
-
Kontakt:
- Fabian BLANC
- Telefonnummer: +33 0668248182
- E-post: fabian-blanc@chu-montpellier.fr
-
-
APHM
-
Marseille, APHM, Frankrike, 13005
- Richard NICOLLAS
-
Kontakt:
- Richard NICOLLAS, PhD
- Telefonnummer: +33 0491386709
- E-post: richard.nicollas@ap-hm.fr
-
-
APHP Hôpital Necker
-
Paris, APHP Hôpital Necker, Frankrike, 75006
- François SIMON
-
Kontakt:
- François SIMON, PhD
- Telefonnummer: +33 0153104600
- E-post: f.simon@aphp.fr
-
-
APHP Hôpital Robert Debre
-
Paris, APHP Hôpital Robert Debre, Frankrike, 75019
- Thiery VAN DEN ABBEELE
-
Kontakt:
- Thiery VAN DEN ABBEELE, PhD
- Telefonnummer: +33 0140032179
- E-post: thierry.van-den-abbeele@aphp.fr
-
Underutredare:
- Natacha TEISSIER, PhD
-
Underutredare:
- Charlotte BENOIT, Dr
-
Underutredare:
- Emilie BOIS, Dr
-
-
HCL Hôptial Femme Mere Enfant
-
Lyon, HCL Hôptial Femme Mere Enfant, Frankrike, 69677
- Sonia AYARI
-
Kontakt:
- Sonia AYARI, PhD
- Telefonnummer: +33 0427855729
- E-post: sonia.ayari-khalfallah@chu-lyon.fr
-
Underutredare:
- Aurélie COUDERT, Dr
-
Underutredare:
- Maxime TABEY, Dr
-
-
Hôpital Purpan
-
Toulouse, Hôpital Purpan, Frankrike, 40031
- Marie-Noël CALMELS
-
Kontakt:
- Marie-Noël CALMES, PhD
- Telefonnummer: +33 0561779009
- E-post: calmels.mn@chu-toulouse.fr
-
Underutredare:
- Blandine BALADI
-
Underutredare:
- Yohan GALLOIS
-
-
Hôpital Salengro
-
Lille, Hôpital Salengro, Frankrike, 5900
- Philippine TOULEMONDE
-
Kontakt:
- Philippine TOULEMONDE, Dr
- Telefonnummer: +33 0320446205
- E-post: philippine.toulemonde@chu-lille.fr
-
Underutredare:
- Hugo DELERRY
-
Underutredare:
- Christophe VINCENT
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Children aged strictly between 8 and 17 years of age
- Presenting a posterior mesotympanic retraction (grade II or III without adherence to the promontory from Sade's grade) with effusion
Exclusion Criteria:
- Weight strictly less than 20kg
- Down syndrome
- Craniosynostosis and other head and neck malformations
- History of skull base surgery
- History of skull fracture
- Failure to obtain consent
- Non-affiliation to a social security scheme
- Persons placed under legal protection
- Person participating in another research including a period of exclusion still in progress
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Eustachian tube dilation added to standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present. ETD involves using a transnasal balloon catheter, during general anesthesia, by the surgeon in charge of the patient. The device will be an Acclarent Aera 6x16 mm balloon, with a pressure set at 12 atm for 2 minutes in the eustachian tube. The manufacturer of the ETD device will organize a training session with hands-on on simulator, for all the principal investigators prior to the start of the study, to ensure homogenous intervention. |
Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical, coupled with the Acclarent Aera™ Eustachian Tube Balloon Dilation System. |
|
Aktiv komparator: Standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present, during general anesthesia, by the surgeon in charge of the patient. Tube placement will be in the anterior or inferior part of the tympanic membrane. Different design and brand of tympanostomy tube exist and are used in the different centers, leading to putative slightly different outcomes in term of adverse events related to the tympanostomy tube and duration. To decrease the cohort's heterogeneity, we propose to utilize the same tympanostomy tube for all the patients included in the study (Shepard's tympanostomy tube). |
Medical device: Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Tympanic membrane retraction
Tidsram: Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
The assessment of tympanic membrane retraction is treated as a survival variable. Tympanic membrane retraction will be blindly assessed by an adjudication committee, through recorded otoendoscopy, based on the Sade's classification (in grade 0, I, II, III, IV, or V). The delay will be calculated as the time from intervention to improvement in tympanic membrane retraction (event), to loss of follow up (censoring), or to the study endpoint (censoring). |
Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Mesotympanic retractation
Tidsram: 6, 12 and 18 months
|
Mesotympanic retractation according to Sade's classification |
6, 12 and 18 months
|
|
Audiometry thresholds
Tidsram: 6, 12 and 18 months
|
Mean of the air-bone gap at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz |
6, 12 and 18 months
|
|
Tympanometry profile
Tidsram: 6, 12 and 18 months
|
Tympanometry profile (A, B or C) |
6, 12 and 18 months
|
|
The quality of life
Tidsram: 6, 12 and 18 months
|
Quality of Life measured through the OM-6 questionnaires |
6, 12 and 18 months
|
|
The quality of life
Tidsram: 6, 12 and 18 months
|
Quality of Life measured through the PedsQL™ 4.0 questionnaires |
6, 12 and 18 months
|
|
Adverse events in both arms
Tidsram: during the first week
|
Occurrence of adverse events and serious events during the first week, coded according to MedDRA. |
during the first week
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Fabian BLANC, Dr, University Hospital, Montpellier
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RECHMPL26_0029
- 2026-A01144-47 (Annan identifierare: ID-RCB)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .